FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313304196> ?p ?o ?g. }

• W4313304196 endingPage "e065112" @default.
• W4313304196 startingPage "e065112" @default.
• W4313304196 abstract "Objective Patients with advanced chronic kidney disease (CKD) or kidney failure receiving replacement therapy (KFRT) are highly vulnerable to COVID-19 infection, morbidity and mortality. Vaccination is effective, but access differs around the world. We aimed to ascertain the availability, readiness and prioritisation of COVID-19 vaccines for this group of patients globally. Setting and participants Collaborators from the International Society of Nephrology (ISN), Dialysis Outcomes and Practice Patterns Study and ISN-Global Kidney Health Atlas developed an online survey that was administered electronically to key nephrology leaders in 174 countries between 2 July and 4 August 2021. Results Survey responses were received from 99 of 174 countries from all 10 ISN regions, among which 88/174 (50%) were complete. At least one vaccine was available in 96/99 (97%) countries. In 71% of the countries surveyed, patients on dialysis were prioritised for vaccination, followed by patients living with a kidney transplant (KT) (62%) and stage 4/5 CKD (51%). Healthcare workers were the most common high priority group for vaccination. At least 50% of patients receiving in-centre haemodialysis, peritoneal dialysis or KT were estimated to have completed vaccination at the time of the survey in 55%, 64% and 51% of countries, respectively. At least 50% of patients in all three patient groups had been vaccinated in >70% of high-income countries and in 100% of respondent countries in Western Europe. The most common barriers to vaccination of patients were vaccine hesitancy (74%), vaccine shortages (61%) and mass vaccine distribution challenges (48%). These were reported more in low-income and lower middle-income countries compared with high-income countries. Conclusion Patients with advanced CKD or KFRT were prioritised in COVID-19 vaccination in most countries. Multiple barriers led to substantial variability in the successful achievement of COVID-19 vaccination across the world, with high-income countries achieving the most access and success." @default.
• W4313304196 created "2023-01-06" @default.
• W4313304196 creator A5002032818 @default.
• W4313304196 creator A5003400873 @default.
• W4313304196 creator A5008185621 @default.
• W4313304196 creator A5010462785 @default.
• W4313304196 creator A5015788445 @default.
• W4313304196 creator A5020962784 @default.
• W4313304196 creator A5036497292 @default.
• W4313304196 creator A5039438278 @default.
• W4313304196 creator A5069292335 @default.
• W4313304196 creator A5072721946 @default.
• W4313304196 creator A5083226860 @default.
• W4313304196 creator A5083391210 @default.
• W4313304196 creator A5088349178 @default.
• W4313304196 date "2022-12-01" @default.
• W4313304196 modified "2023-09-25" @default.
• W4313304196 title "Availability and prioritisation of COVID-19 vaccines among patients with advanced chronic kidney disease and kidney failure during the height of the pandemic: a global survey by the International Society of Nephrology" @default.
• W4313304196 cites W3036315891 @default.
• W4313304196 cites W3046356037 @default.
• W4313304196 cites W3048702451 @default.
• W4313304196 cites W3093278122 @default.
• W4313304196 cites W3095404113 @default.
• W4313304196 cites W3107073026 @default.
• W4313304196 cites W3112865356 @default.
• W4313304196 cites W3113930329 @default.
• W4313304196 cites W3114837738 @default.
• W4313304196 cites W3121611393 @default.
• W4313304196 cites W3123000919 @default.
• W4313304196 cites W3130715422 @default.
• W4313304196 cites W3132721190 @default.
• W4313304196 cites W3137479357 @default.
• W4313304196 cites W3152781341 @default.
• W4313304196 cites W3154882088 @default.
• W4313304196 cites W3159987177 @default.
• W4313304196 cites W3182978015 @default.
• W4313304196 cites W3183564574 @default.
• W4313304196 cites W3186501640 @default.
• W4313304196 cites W3190407105 @default.
• W4313304196 cites W3192631736 @default.
• W4313304196 cites W3207316690 @default.
• W4313304196 cites W3209089368 @default.
• W4313304196 cites W3212220471 @default.
• W4313304196 cites W3212544729 @default.
• W4313304196 cites W3214771257 @default.
• W4313304196 cites W3215990933 @default.
• W4313304196 cites W3216507411 @default.
• W4313304196 cites W4200248237 @default.
• W4313304196 cites W4200320281 @default.
• W4313304196 cites W4200554237 @default.
• W4313304196 cites W4205742435 @default.
• W4313304196 cites W4226023479 @default.
• W4313304196 cites W4226127912 @default.
• W4313304196 doi "https://doi.org/10.1136/bmjopen-2022-065112" @default.
• W4313304196 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36585149" @default.
• W4313304196 hasPublicationYear "2022" @default.
• W4313304196 type Work @default.
• W4313304196 citedByCount "1" @default.
• W4313304196 countsByYear W43133041962023 @default.
• W4313304196 crossrefType "journal-article" @default.
• W4313304196 hasAuthorship W4313304196A5002032818 @default.
• W4313304196 hasAuthorship W4313304196A5003400873 @default.
• W4313304196 hasAuthorship W4313304196A5008185621 @default.
• W4313304196 hasAuthorship W4313304196A5010462785 @default.
• W4313304196 hasAuthorship W4313304196A5015788445 @default.
• W4313304196 hasAuthorship W4313304196A5020962784 @default.
• W4313304196 hasAuthorship W4313304196A5036497292 @default.
• W4313304196 hasAuthorship W4313304196A5039438278 @default.
• W4313304196 hasAuthorship W4313304196A5069292335 @default.
• W4313304196 hasAuthorship W4313304196A5072721946 @default.
• W4313304196 hasAuthorship W4313304196A5083226860 @default.
• W4313304196 hasAuthorship W4313304196A5083391210 @default.
• W4313304196 hasAuthorship W4313304196A5088349178 @default.
• W4313304196 hasBestOaLocation W43133041961 @default.
• W4313304196 hasConcept C126322002 @default.
• W4313304196 hasConcept C138816342 @default.
• W4313304196 hasConcept C142724271 @default.
• W4313304196 hasConcept C177713679 @default.
• W4313304196 hasConcept C203014093 @default.
• W4313304196 hasConcept C22070199 @default.
• W4313304196 hasConcept C2778653478 @default.
• W4313304196 hasConcept C2779056158 @default.
• W4313304196 hasConcept C2779134260 @default.
• W4313304196 hasConcept C2779978075 @default.
• W4313304196 hasConcept C3008058167 @default.
• W4313304196 hasConcept C46578552 @default.
• W4313304196 hasConcept C512399662 @default.
• W4313304196 hasConcept C524204448 @default.
• W4313304196 hasConcept C54847362 @default.
• W4313304196 hasConcept C71924100 @default.
• W4313304196 hasConcept C89623803 @default.
• W4313304196 hasConceptScore W4313304196C126322002 @default.
• W4313304196 hasConceptScore W4313304196C138816342 @default.
• W4313304196 hasConceptScore W4313304196C142724271 @default.
• W4313304196 hasConceptScore W4313304196C177713679 @default.
• W4313304196 hasConceptScore W4313304196C203014093 @default.
• W4313304196 hasConceptScore W4313304196C22070199 @default.
• W4313304196 hasConceptScore W4313304196C2778653478 @default.

• next